콜라겐 펩타이드 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the global collagen peptides market size was valued at USD 1.84 billion in 2025 and estimated to grow from USD 1.98 billion in 2026 to reach USD 2.96 billion by 2031, at a CAGR of 8.43% during the forecast period (2026-2031).

This report is Segmented by Product Type (Bovine, Porcine, Poultry, and Fish), Source (Bones and Hides and Skin), Molecular Weight (1-3 Kilodaltons (kDa), 3-5 Kilodaltons (kDa), and More), Application (Food and Beverages, Pharmaceuticals and More), and Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Collagen Peptides Market Trends and Insights

Rise of personalized nutrition and targeted collagen supplementation

The global dietary supplement market is shifting from generic, broad-spectrum formulations to precision-engineered nutritional solutions designed to deliver clinically validated results for specific physiological functions, with collagen peptides playing a pivotal role in this evolution. Rousselot's launch of the Nextida platform at Vitafoods Europe 2024 exemplifies the growing emphasis on personalized nutrition, transforming collagen peptides from a basic protein commodity into a portfolio of bioactive compositions targeting specific biological needs. This platform, described as a "GPS for the body," uses rigorous cellular model testing to identify optimal peptide compositions that act as precise biological signals, guiding the body toward balance restoration. At Vitafoods Europe 2025, Rousselot showcased its science-backed innovation, Nextida GC, to support post-meal glucose management. Meanwhile, advancements in artificial intelligence and bioengineering are accelerating the development of precision collagen peptide compositions, enabling the creation of human-identical, mechanism-specific collagen fragments.

Growing commercialization of collagen peptides in sports nutrition products

The sports nutrition category, a key commercial channel for collagen peptides targeting athletic and active consumers, is witnessing robust global growth. According to Mordor Intelligence, the global sports nutrition market was valued at USD 35,800.7 million in 2025, offering a significant opportunity for collagen peptide inclusion. Supplement brands are increasingly incorporating collagen peptides into recovery-specific SKUs, joint-support formulations, and multi-benefit active nutrition products to cater to the evolving needs of this expanding consumer base. The demand for sports recovery supplementation is accelerating, driven by a surge in participation in physical activity. According to the Sports and Fitness Industry Association's (SFIA) 2025 Topline Participation Report, 80% of Americans were actively engaged in physical activities in 2024, representing 247.1 million individuals, an increase of 25.4 million active participants since 2019. This growing pool of fitness enthusiasts and athletes represents a substantial market for recovery nutrition solutions, where collagen peptides are becoming a key ingredient.

Stringent regulations related to animal-derived ingredients, traceability, and labeling

The growth of the collagen peptide market is being hindered by stringent regulations surrounding animal-based ingredients, traceability, and labeling requirements. Collagen peptides, derived from sources such as bovine hides, porcine skin, poultry cartilage, fish scales, bones, and tendons, are subject to rigorous food safety, veterinary, and hygiene standards, particularly in key markets like Europe, the United States, and the United Kingdom. These regulations, aimed at ensuring ethical sourcing and consumer safety, have led to higher certification costs, longer approval timelines, and increased trade barriers. Manufacturers face significant challenges navigating complex import and traceability rules, as evidenced by the European Commission's strict health certification requirements for animal-based products entering Europe. The situation intensified in April 2026 when the European Union expanded the list of products requiring mandatory border checks, compelling collagen peptide exporters to maintain detailed sourcing records to avoid shipment delays.

Other drivers and restraints analyzed in the detailed report include:

1. Rising consumer focus on preventive healthcare and healthy aging
2. Mainstreaming of "food as medicine" philosophy and functional food culture
3. Adoption of alternative functional ingredients for joint health, bone support, and beauty applications

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Bovine collagen peptides are expected to maintain their dominance in the global collagen peptides market, accounting for 46.23% of total market revenue by 2025. This strong position is attributed to their widespread availability, cost-effectiveness, and versatile applications across industries such as food and beverage, nutraceuticals, and personal care. Additionally, bovine-derived collagen is favored for its rich amino acid profile and high functionality, appealing to both manufacturers and consumers. Its adaptability in various formulations further strengthens its market presence. These factors collectively make bovine collagen peptides a preferred choice in the industry.

Fish collagen peptides are anticipated to be the fastest-growing product segment, with a projected CAGR of 11.79% over the forecast period of 2026-2031. The growing consumer demand for marine-sourced ingredients is a key driver of this growth. Furthermore, the rising demand for clean-label and sustainably sourced products aligns with the growing popularity of fish collagen. Known for its superior bioavailability, fish collagen is increasingly utilized in beauty-from-within supplements, functional foods, and skincare products. This trend highlights the expanding role of fish collagen in meeting consumer preferences for health and sustainability.

Hides and skins remain the largest raw material segment in the global collagen peptides market, accounting for 71.68% of total market revenue in 2025. This leadership is primarily due to their widespread availability from the meat processing industry, which ensures a steady and cost-effective supply. Hides and skins offer a high collagen yield, making them a preferred choice for large-scale production. Their established supply chains further enhance their suitability for use in various applications, including food, nutraceuticals, and cosmetics. The consistent demand for these raw materials underscores their critical role in meeting the growing demand for collagen peptides.

Bones are expected to be one of the fastest-growing raw material categories, with a CAGR of 9.64% through 2031. This growth is driven by increasing efforts to utilize by-products effectively, thereby promoting sustainability across the value chain. The focus on reducing raw material waste has further encouraged the adoption of bone-derived collagen peptides. Technological advancements in extraction processes have also made it easier to harness collagen from bones, enhancing their appeal as an alternative source. Moreover, the rising demand for sustainable, eco-friendly collagen sources is expected to drive the use of bone-based collagen peptides across diverse end-use industries.

Complete Report Scope:

• By Product Type
  • Bovine
  • Porcine
  • Fish
  • Poultry
• By Source
  • Bones
  • Hides and Skins
• By Molecular Weight
  • Less than 1 kilodalton (kDa)
  • 1-3 kilodaltons (kDa)
  • 3-5 kilodaltons (kDa)
  • Greater than 5 kilodaltons (kDa)
• By Application
  • Pharmaceuticals
  • Dietary Supplements
  • Food and Beverages
  • Other Applications
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Netherlands
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • South America
  • Middle East and Africa

Geography Analysis

North America continues to dominate the global collagen peptides market, accounting for 34.14% of total revenue in 2025. The region's leadership is attributed to its well-established dietary supplement industry, high consumer expenditure on wellness products, and the increasing use of collagen to improve joint, bone, and overall health. The United States, Canada, and Mexico are key contributors, driven by growing awareness among healthcare professionals and consumers about collagen's health benefits. Additionally, the availability of advanced manufacturing facilities and a strong distribution network further supports market growth in the region. The rising trend of preventive healthcare and personalized nutrition also plays a pivotal role in sustaining demand for collagen peptides.

The Asia-Pacific region is anticipated to be the fastest-growing market for collagen peptides, with a projected CAGR of 10.94% through 2031. This growth is fueled by increasing health consciousness, a surge in demand for beauty-from-within products, and the rising consumption of functional foods and dietary supplements. Major markets such as China, Japan, and India are driving regional expansion, supported by a large and growing consumer base, rising disposable incomes, and significant investments in collagen peptide production. Furthermore, the region's focus on innovative product development and the incorporation of collagen in traditional diets are boosting its market potential. The increasing popularity of marine-sourced collagen, particularly in Japan and South Korea, is also contributing to this growth.

Europe holds a substantial share of the global collagen peptides market, driven by strong demand for clean-label, functional, and fortified food products. Consumers in the region are increasingly prioritizing ingredient transparency, sustainability, and premium-quality nutrition, which has led to higher adoption of collagen-based products. Countries like Germany, France, and the United Kingdom are key markets, supported by robust research and development activities and a growing focus on health and wellness. Meanwhile, South America and the Middle East and Africa are emerging as promising markets, benefiting from increasing awareness of collagen's health benefits, expanding supplement consumption, and the availability of bovine raw materials. The introduction of halal-certified collagen products is further enhancing market opportunities in these regions.

1. GELITA AG
2. Darling Ingredients
3. Nitta Gelatin Inc.
4. Amicogen, Inc.
5. Thai Union Group PCL
6. Nippi, Inc.
7. Titan Biotech Ltd.
8. Hangzhou Nutrition Biotechnology Co., Ltd
9. Weishardt Group.
10. Tessenderlo Group NV
11. Athos Collagen Pvt. Ltd.
12. Shandong Hengxin Biotech Co., Ltd
13. Baotou Dongbao Bio-Tech Co., Ltd.
14. Fujian Funingpu Biotechnology Co., Ltd
15. Sichuan Raybo Biotechnology Co., Ltd
16. Shandong JiRuITe (JRT) Gelatin Co., Ltd

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rise of personalized nutrition and targeted collagen supplementation
  • 4.2.2 Growing commercialization of collagen peptides in sports nutrition products
  • 4.2.3 Increasing popularity of beauty-from-within and nutricosmetics
  • 4.2.4 Rising consumer focus on preventive healthcare and healthy aging
  • 4.2.5 Mainstreaming of "food as medicine" philosophy and functional food culture
  • 4.2.6 Increasing adoption in pharmaceutical and medical nutrition applications
• 4.3 Market Restraints
  • 4.3.1 Stringent regulations related to animal-derived ingredients, traceability, and labeling
  • 4.3.2 High production and hydrolysis costs associated with manufacturing specialized collagen peptides
  • 4.3.3 Adoption of alternative functional ingredients for joint health, bone support, and beauty applications
  • 4.3.4 Fluctuations in the availability and pricing of bovine, porcine, and marine raw materials
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Outlook
• 4.6 Raw Material Analysis
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Bargaining Power of Suppliers
  • 4.7.4 Threat of Substitute Products
  • 4.7.5 Intensity of Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE AND VOLUME)

• 5.1 By Product Type
  • 5.1.1 Bovine
  • 5.1.2 Porcine
  • 5.1.3 Fish
  • 5.1.4 Poultry
• 5.2 By Source
  • 5.2.1 Bones
  • 5.2.2 Hides and Skins
• 5.3 By Molecular Weight
  • 5.3.1 Less than 1 kilodalton (kDa)
  • 5.3.2 1-3 kilodaltons (kDa)
  • 5.3.3 3-5 kilodaltons (kDa)
  • 5.3.4 Greater than 5 kilodaltons (kDa)
• 5.4 By Application
  • 5.4.1 Pharmaceuticals
  • 5.4.2 Dietary Supplements
  • 5.4.3 Food and Beverages
  • 5.4.4 Other Applications
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
    • 5.5.1.4 Rest of North America
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 Italy
    • 5.5.2.4 France
    • 5.5.2.5 Spain
    • 5.5.2.6 Netherlands
    • 5.5.2.7 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 Japan
    • 5.5.3.3 India
    • 5.5.3.4 Australia
    • 5.5.3.5 Rest of Asia-Pacific
  • 5.5.4 South America
  • 5.5.5 Middle East and Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategies Adopted by Leading Players
• 6.3 Market Share Analysis
• 6.4 Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
  • 6.4.1 GELITA AG
  • 6.4.2 Darling Ingredients
  • 6.4.3 Nitta Gelatin Inc.
  • 6.4.4 Amicogen, Inc.
  • 6.4.5 Thai Union Group PCL
  • 6.4.6 Nippi, Inc.
  • 6.4.7 Titan Biotech Ltd.
  • 6.4.8 Hangzhou Nutrition Biotechnology Co., Ltd
  • 6.4.9 Weishardt Group.
  • 6.4.10 Tessenderlo Group NV
  • 6.4.11 Athos Collagen Pvt. Ltd.
  • 6.4.12 Shandong Hengxin Biotech Co., Ltd
  • 6.4.13 Baotou Dongbao Bio-Tech Co., Ltd.
  • 6.4.14 Fujian Funingpu Biotechnology Co., Ltd
  • 6.4.15 Sichuan Raybo Biotechnology Co., Ltd
  • 6.4.16 Shandong JiRuiTe (JRT) Gelatin Co., Ltd

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK